Company intelligence / Profile preview

Endomedica

Halle, Saxony-Anhalt, Germanyendomedica.de ↗

Ownership: Private
Development stage: Other

Overview

Endomedica is the German marketing and distribution subsidiary of AMW GmbH. It markets leuprorelin implants (Leugon®) that provide controlled drug release for improved treatment compliance

Therapeutic areas: Endocrinology
Modalities: Biodegradable implant-based drug delivery systems
Industry: Biotech

Partnerships

Parent company AMW GmbH collaborates with pharmaceutical and biotech partners worldwide for product development and manufacturing

Beyond the preview

Go deeper on Endomedica.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Endomedica.